baber/WOPTO huggingface dataset:
Patent SG-54246-A1 (SG)
Title: Electrofusion fastening apparatus
Inventor: MASARU KUMAGAI
IPC: B29C65/00
Filed: 1994-12-14
Abstract: Electrofusion fastening apparatus comprises a control box (1) for detecting incorrect assembly of a pipe fitting (16) and pipe (17) and aborts the welding operation without destroying the fitting. Electrofusion fastening apparatus also comprises a control box (1) for measuring the gap between the pipe and fitting and alters the welding parameters to compensate. Electrofusion fastening apparatus warms the pipe and fitting prior to welding to ensure the surfaces are dry. A socket for electrofusion welding has a coil (19) buried in the body of its wall. A transition fitting is provided to interface between metal and electrofused components. Electrofusion apparatus includes means (8) for checking the type of fitting to be used. Electrofusion apparatus comprises means for checking that welding is complete, by means of resistance checks and mechanical means and a monitor in the connector.
Patent SG-73414-A1 (SG)
Title: Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
Inventor: WEBER ECKARD
IPC: C07C279/18
Filed: 1991-03-04
Abstract: Tri- and tetra-substituted guanidines which exhibit a high binding affinity to phencyclidine (PCP) receptors and, more preferably, low affinity to the brain sigma receptors. These guanidine derivatives act as non-competitive inhibitors of glutamate induced responses of the NMDA receptor by acting as blockers for the ion channel of the NMDA receptor-ion channel complex. These compounds thus exert neuroprotective activity and are useful in the therapeutic treatment of neuronal loss in hypoxia, hypoglycemia, brain or spinal cord ischemia, and brain or spinal chord trauma as well as being useful for the treatment of epilepsy, Alzheimer's disease, Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, Down's Syndrome, Korsakoff's disease and other neurodegenerative disorders.
Patent SG-65587-A1 (SG)
Title: Biodegradable liquid impervious multilayer film compositions
Inventor: WUNUK ANDREW JULIAN
IPC: A61F13/15
Filed: 1993-06-14
Abstract: Biodegradable, liquid impervious multilayer film compositions are disclosed. In particular, the films comprise composite structures derived from multilayer combinations of biodegradable polymers. The biodegradable polymers are selected from the categories of moisture sensitive polymers, thermally sensitive polymers, mechanically limited polymers, polymers not easily processed into films, hydrolytically cleavable polymers, and degradable elastomers. Optionally, the multilayer films may further comprise additional adhesive tie layers. The biodegradable polymers are combined in various ways to overcome the deficiencies of the individual components, yet at the same time impart specific performance properties to the film. The multilayer film compositions are suitable for use as backsheets in disposable absorbent products including diapers, adult incontinent pads, sanitary napkins, pantiliners, and the like.
Patent WO-2005013588-A1 (WO)
Title: Systeme automatise de reservation et d'envoi de taxis/vehicules
Inventor: NG KIM CHWEE ALBERT
IPC: H04Q7/20
Filed: 2004-07-30
Abstract: L'invention concerne un système de réservation de véhicules comprenant un moyen de communication vocale destiné à permettre à une personne d'effectuer une réservation de véhicule, un système de réponse vocal interactif destiné à inviter la personne à effectuer une demande de réservation, un système d'enregistrement de séquence vocale destiné à enregistrer la demande de réservation. La demande de réservation enregistrée par le système d'enregistrement de séquence est transmise à un véhicule pour exécuter la réservation de véhicule.
Patent WO-2007064304-A1 (WO)
Title: Composition biocompatible et utilisations de celle-ci
Inventor: NEOH KOON GEE
IPC: A61K31/722
Filed: 2006-12-01
Abstract: Cette invention concerne une composition biocompatible et des utilisations de celle-ci. En particulier, l'invention concerne une composition biocompatible avec les os comprenant du chitosan et/ou un dérivé du chitosan. Plus particulièrement, l'invention concerne une composition de ciment osseux comprenant un ciment osseux et du chitosan et/ou un dérivé du chitosan. La présente invention concerne également des utilisations de la composition biocompatible avec les os et un procédé de préparation de celle-ci.
Patent SG-130182-A1 (SG)
Title: A lubricating oil additive composition and method of making the same
Inventor: STOKES CASEY D
Filed: 2006-08-31
Abstract: An oil-soluble lubricating oil additive composition comprising (I) an oil- soluble lubricating oil additive prepared by the process which comprises reacting a copolymer, with at least one ether compound and with at least one aromatic amine and (II) at least one ashless dispersant other than the lubricating oil additive of (I), the method of making the same, a lubricating oil composition comprising the lubricating oil additive composition and a major amount of an oil of lubricating viscosity, and a method of making the same.
Patent SG-136862-A1 (SG)
Title: Variable speed printing
Inventor: BURGER JOHAN H
Filed: 2007-03-15
Abstract: An image reproduction device for document processing is described. Although the device has a nominal processing speed (47) at which it can process sheets continuously at a nominal document quality, it is arranged for processing sheets at a continuously variable processing speed including the nominal processing speed, the actual processing speed being selected in dependence of operational conditions. In particular, the device is arranged for gradually adjusting the processing speed (46) from one processing speed to another processing speed. A control structure is given for selecting the variable processing speed in dependence of operational conditions, and for operating the image reproduction device at the selected processing speed. In a particular application of the variable speed, a print job may be started at an increased processing speed (45) and then gradually fall back to the nominal speed (47), giving a fast start and a shorter processing time for short print jobs.
Patent SG-150460-A1 (SG)
Title: Process for the preparation of polyols
Inventor: LORENZ DR KLAUS
Filed: 2008-08-12
Abstract: PROCESS FOR THE PREPARATION OF POLYOLS The present invention provides polyols which can be obtained by a simple process. These polyols, unless explicitly specified, are to be understood to encompass both polyether polyols and polyether ester polyols. The invention further provides the simple process for the production of the polyols, and also, the production of polyurethanes comprising reacting a polyol according to the invention with a polyisocyanate. Figure: None
Patent SG-160248-A1 (SG)
Title: Use of novel monoclonal antibodies targeting human embryonic stem cells to characterize and kill induced pluripotent stem cells
Inventor: CHOO BOON HWA ANDRE
Filed: 2008-09-18
Abstract: The invention relates to human embryonic stem cell-specific monoclonal antibodies that bind to and characterize IPS cells. The invention also relates to the use of mAb 84 was to kill induced pluripotent stem cells. Fig. None
Patent SG-152148-A1 (SG)
Title: Stabilizers to inhibit the polymerization of substituted cyclotetrasiloxane
Inventor: MAYORGA STEVEN GERARD
Filed: 2008-10-07
Abstract: The present invention is; (a) a process for stabilizing a cyclotetrasiloxane, such as 1,3,5,7- tetramethylcyclotetrasiloxane, against polymerization used in a chemical vapor deposition process for silicon oxides in electronic material fabrication comprising providing an effective amount of an antioxidant polymerization inhibitor to such cyclotetrasiloxane; and (b) a composition of a cyclotetrasiloxane, such as 1,3,5,7-tetramethylcyclotetrasiloxane, stabilized against polymerization used in a chemical vapor deposition process as a precursor for silicon oxides in electronic material fabrication, comprising; such cyclotetrasiloxane and an antioxidant.
Patent WO-2011008170-A1 (WO)
Title: Etiquette didentification radiofréquence pour la détection de bétail
Inventor: HUANG TOON LIANG
IPC: A01K11/00
Filed: 2009-07-15
Abstract: Linvention concerne un ensemble étiquette (200) didentification radiofréquence (RFID) qui convient pour la détection de bétail. Lensemble étiquette RFID comprend une partie mâle (110), une partie femelle (120) et un élément support (130). La partie femelle est conçue pour recevoir la partie mâle, et lélément support est couplé aux parties mâle et femelle. Lélément support comporte un dispositif (131) de communication RFID qui comprend un transpondeur (131a) et une bobine RFID couplée au transpondeur. Dans certaines formes de réalisation, la bobine RFID (131b) présente une épaisseur inférieure à environ 2 millimètres (mm). Dans une forme de réalisation, la bobine RFID présente un diamètre intérieur denviron 9mm et un diamètre extérieur denviron 16mm.
Patent WO-2010021600-A1 (WO)
Inventor: YING JACKIE Y
IPC: C22B23/00
Filed: 2009-08-21
Abstract: The present invention generally relates to compositions and methods comprising polyoxometalates (POMs). In some cases, a reduced form of a POM may be formed via electrolysis in the presence of essentially no supporting electrolyte. The reduced POMs may be used for various applications, for example, for the formation of metallic nanoparticles. Some embodiments of the present invention provide compositions and methods comprising reduced forms of the polyoxometalate, [alpha-SiW 12 O 40 ] 4- .
Patent WO-2013048334-A1 (WO)
Title: Small molecules for extending the well being of cells and methods of use thereof
Inventor: SENG ENG KHUAN
IPC: A61P17/00
Filed: 2011-09-26
Abstract: The present invention relates to use of a series of compounds and compositions comprising the same for enhancing telomerase expression and/or activating telomerase activity in a cell or tissue of a subject and for treatment of diseases, disorders and/or conditions capable of being affected by enhanced telomerase expression and/or telomerase activation.
Patent SG-170075-A1 (SG)
Title: R-fe-b rare earth sintered magnet and method for producing same
Inventor: YOSHIMURA KOSHI
Filed: 2007-03-01
Abstract: In a method for producing an R-Fe-B based rare-earth sintered magnet according to the present invention, first, provided is an R-Fe-B based rare- earth sintered magnet body including, as a main phase, crystal grains of an R2Fe14B type compound that includes a light rare-earth element RL, which is at least one of Nd and Pr, as a major rare-earth element R. Thereafter, the sintered magnet body is heated while a heavy rare-earth element RH, which is at least one element selected from the group consisting of Dy, Ho and Tb, is supplied to the surface of the sintered magnet body, thereby diffusing the heavy rare-earth element RH into the rare-earth sintered magnet body.
Patent SG-185846-A1 (SG)
Title: Manually-actuated reduced treatment system having regulated pressure capabilities
Inventor: COULTHARD RICHARD DANIEL JOHN
Filed: 2009-05-01
Abstract: MANUALLY-ACTUATED REDUCED PRESSURE TREATMENT SYS IEM HAVING REGULAILD PRESSURE CAPABILITIES Abstract:A reduced-pressure treatment system includes a manifold to be positioned at a tissue site, a regulated chamber, and a charging chamber. The regulated chamber is in fluidcommunication with the tissue site to deliver a desired therapy pressure to the tissue site. Thecharging chamber is adapted to store a charging pressure that is less than the desired therapypressure. The reduced-pressure treatment system also includes a passage that provides fluidcommunication between the regulated chamber and the charging chamber, as well as a valvebody. The valve body is operably associated with the passage to substantially reduce fluidcommunication through the passage when the pressure in the regulated chamber is less than or equal to the desired therapy pressure and to allow fluid communication through the passage when the pressure in the regulated chamber exceeds the desired therapy pressure.(FIG. 9)
Patent SG-171954-A1 (SG)
Title: Pyridazinone derivatives
Inventor: ALBERATI DANIELA
Filed: 2009-11-24
Abstract: The present invention is concerned with novel pyridazinone derivatives of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as medicaments.
Patent SG-176141-A1 (SG)
Title: Electromagnetic shielding article
Inventor: ROMANKO WALTER R
Filed: 2010-05-19
Abstract: A shielding article includes a first conductive layer and a second conductive layer spaced apart from the first conductive layer by a non-conductive polymeric layer defining a separation distance. The first conductive layer and the second conductive layer cooperatively provide a first shielding effectiveness. The first conductive layer, the second conductive layer, and the separation distance cooperatively provide a second shielding effectiveness that is greater than the first shielding effectiveness.
Patent SG-177887-A1 (SG)
Title: Method for replicating influenza virus in culture
Inventor: WASMOEN TERRI LEE
Filed: 2007-12-14
Abstract: Abstract Title: METHOD FOR REPLICATING INFLUENZA VIRUS ON CULTUREThe invention is related to a method for selecting an influenza virus for growth on tissue culture cells to produce a tissue-culture adapted viral isolate. The invention also includes vaccines produced from the isolate.Figure 02.
Patent SG-177294-A1 (SG)
Title: Traditional chinese medicine composition to treat bronchial asthma and preparation method thereof
Inventor: WU YILING
IPC: A61K35/63
Filed: 2009-07-09
Abstract: Traditional Chinese Medicine Composition to Treat Bronchial Asthma andThe present invention provides a traditional Chinese medicine composition for treating Bronchial Asthma and preparation method thereof. The traditional Chinese medicine composition is prepared from pure plant raw material drugs including Herba Ephedrae, SemenGinkgo , Cortex Mori, Radix Scutellariae, Semen Armeniacae Amarum, Rhizoma Pinelliae,Fructus Perillae, Flos Farfarae and so on. The traditional Chinese medicine composition is effective in treating Bronchial asthma.
Patent SG-193684-A1 (SG)
Title: Incinerator with a smoke treating device
Inventor: WONG TIN CHEUNG
Filed: 2012-06-20
Abstract: INCINERATOR WITH A SMOKE TREATING DEVICEAbstract 5 The present invention provides an incinerator, comprising a burning cavity and asmoke treating device for receiving and treating the smoke generated from the burning cavity. The smoke treating device comprises an exhaust catalyst, a Venturi scrubber, a cyclone scrubber, a cyclone water remover, an electrostatic dust remover, and a draft fan, all of them being located along the flowing direction of the smoke in10 this order. The smoke treating device further comprises a heat exchanger with a hot cavity arranged between the exhaust catalyst and the Venturi scrubber and a cool cavity arranged between the draft fan and the discharging port of the smoke treating device. 15 (Fig. 1)
Patent SG-182416-A1 (SG)
Title: Parallel plate reactor for uniform thin film deposition with reduced tool foot-print
Inventor: MAI JOACHIM
Filed: 2010-07-09
Abstract: The present invention relates to a capacitive-coupled parallel plate plasma enhanced chemical vapour deposition reactor, comprising a gas distribution unit being integrated in an RF electrode and comprising a gas outlet. It is the object of the present invention to provide parallel plate reactor of the referenced type with what layers with high thickness homogeneity and quality can be produced. The object is solved by a capacitive-coupled parallel plate plasma enhanced vapour deposition reactor of the mentioned type wherein the gas distribution unit comprises a multiple-stage showerhead constructed in such a way that it provides an independent adjustment of gas distribution and gas emission pro- file of the gas distribution unit.
Patent SG-185616-A1 (SG)
Title: Machine for producing packaging cushioning
Inventor: MIERZEJEWSKI KENNETH J
Filed: 2011-05-18
Abstract: A machine (10) for producing packaging cushioning generally includes a first feed mechanism (12) for successively feeding sheets (18) of a substrate at a first speed, the first feed mechanism (14) including a motor and a power supply therefor, a second feed mechanism for receiving the sheets from the first feed mechanism and feeding the sheets at a second speed, a control unit (16) for controlling at least one of the first and second speeds to produce a desired degree of overlap between successive sheets, and a sensor (112) to measure the amount of electricity drawn by the motor. The control unit modulates the amount of electricity that the motor draws from a power supply when a signal from the sensor has a value that is greater than or equal to a predetermined value.
Patent SG-187765-A1 (SG)
Title: Method of making 6-hydroxyhexanophenone and 5-benzoylpentanoic acid and mono or diesters thereof
Inventor: WANG KUN
Filed: 2011-08-04
Abstract: Mono- or diester plasticizers of the formula (I): wherein A is either -OC(0)R' or =0, and X is either -COC(0)R or -C(0)OR, and R and R' are C3 to C13 alkyl, which are the same or different, formed from cyclohexylbenzene and processes of making them.
Patent SG-190094-A1 (SG)
Title: Water clarification method and device
Inventor: CAPEAU PATRICE
IPC: C02F11/147
Filed: 2011-10-28
Abstract: The invention relates to a method and device for clarifying water by means treatment of the colloidal structures contained in a liquid and/or a sludge supplied in a continuous flow at a flow rate of QEB = VEB/hour. The flow is sprayed into a chamber (2) under overpressure conditions in relation to atmospheric pressure, said chamber (2) having a volume v < VEB/20, and air (10) being injected simultaneously therein at a flow rate d.
Patent SG-191625-A1 (SG)
Title: Dual variable domain immunoglobulins and uses thereof
Inventor: GHAYUR TARIQ
Filed: 2009-06-03
Abstract: DUAL VARIABLE DOMAIN I MUNOGLOBULINS AND USES THEREOF Abstract 5 The present invention relates to engineered multivalent and multispecific bindingproteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.Figure I
Patent SG-192628-A1 (SG)
Title: Subsea structure flowline connector assembly
Inventor: LUGO MARIO RENE
Filed: 2012-12-11
Abstract: A subsea structure flowline connector assembly for a subsea structure having a flowline connector assembly adapted to be mountable to the subsea structure, the flowline connector assembly having a junction plate having a flowline connector therein; an receiver affixed to or adjacent to said junction plate, said receiver having an interior exposed to said flowline connector of said junction plate; a fly-in connector assembly adapted to be connectable to the flowline connector, said fly-in connector assembly having a connector thereon, said connector of said fly-in connector assembly adapted to engage said flowline connector of said junction plate to establish fluid communication, said fly-in connector assembly having a conduit in communication with said connector of said fly-in connector assembly, said conduit adapted to connect to a flowline; an actuating device coupled to the connector for actuating the connector to engage the flowline connector, a brace extending from the actuating device to the conduit for bracing the conduit to the actuating device.
Patent SG-192743-A1 (SG)
Title: Multi-metric filtering
Inventor: CHONG IN SUK
Filed: 2012-02-22
Abstract: A filter unit of a video encoder or video decoder can determine a first metric for a group of pixels within a block of pixels based on a comparison of a subset of the pixels in the block to other pixels in the block; determine a filter based on the first metric; and generate a filtered image by applying the filter to the group of pixels. The subset of pixels can be selected to not include pixels on the boundary of the block of pixels.
Patent SG-194026-A1 (SG)
Title: Microorganisms for producing methacrylic acid and methacrylate esters and methods related thereto
Inventor: BURK MARK J
Filed: 2012-03-30
Abstract: The invention provides a non-naturally occurring microbial organism having a methacrylic acid, methacrylate ester, 3-hydroxyisobutyrate and/or 2-hydroxyisobutyrate pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in a methacrylic acid pathway. The invention additionally provides a method for producing methacrylic acid, methacrylate ester, 3-hydroxyisobutyrate and/or 2- hydroxyisobutyrate. The method can include culturing methacrylic acid, methacrylate ester, 3-hydroxyisobutyrate and/or 2-hydroxyisobutyrate producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a methacrylic acid pathway enzyme in a sufficient amount to produce methacrylic acid, methacrylate ester, 3-hydroxyisobutyrate and/or 2-hydroxyisobutyrate, under conditions and for a sufficient period of time to produce methacrylic acid, methacrylate ester, 3-hydroxyisobutyrate and/or 2-hydroxyisobutyrate.
Patent SG-194211-A1 (SG)
Title: Reforming catalyst and process
Inventor: LAPINSKI MARK P
Filed: 2012-06-11
Abstract: One exemplary embodiment can be a catalyst for catalytic reforming of naphtha. The catalyst can have a noble metal including one or more of platinum, palladium, rhodium, ruthenium, osmium, and iridium, a lanthanide-series metal including one or more elements of atomic numbers 57-71 of the periodic table, and a support. Generally, an average bulk density of the catalyst is 0.300 - 0.620 gram per cubic centimeter, and an atomic ratio of the lanthanide-series metal: noble metal is less than 1.3: 1. Moreover, the lanthanide-series metal can be distributed at a concentration of the lanthanide-series metal in a 100 micron surface layer of the catalyst less than two times a concentration of the lanthanide-series metal at a central core of the catalyst.
Patent SG-195054-A1 (SG)
Title: Stable liquid formulation of etanercept
Inventor: CHOI SUK YOUNG
Filed: 2012-06-01
Abstract: The present invention relates to a stable liquid formulation of etanercept (recombinant p75 sTNFR:Fc fusion protein), and more particularly, to a liquid formulation comprising one or more stabilizers selected from the group consisting of methionine, lysine, histidine, and pharmaceutically acceptable salts thereof in an amount sufficient to reduce by-product formation of etanercept during storage. The liquid formulation according to the present invention effectively reduces production of etanercept by-products and to stably maintain its pharmaceutical efficacies for long-term storage. Therefore, the reconstitution procedure is not required before administration, and the sterile formulation can be administered to patients to ensure patient safety. Thus, it can be applied to the fields in need of etanercept treatment.